Earnings History Data for ADMA Biologics Inc (ADMA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ADMA Biologics Inc

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		ADMA	ADMA Biologics Inc	4,390	0.15	0.13	0.01	ADMA Biologics GAAP EPS of $0.15 beats by $0.02, revenue of $119.8M beats by $13.95M [11/7/2024 4:29 PM]	22.39	2.67 (13.54%)	20.80	1.08 (5.48%)	3.56 - 23.52	8,471,116	4,030,000	87,737
ADMA Biologics GAAP EPS of $0.15 beats by $0.02, revenue of $119.8M beats by $13.95M [11/7/2024 4:29 PM] ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know Ahead Of Earnings [Nov-06-24 07:08AM] ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update [2024-11-07 04:05PM] Adma Biologics: Q3 Earnings Snapshot [2024-11-07 06:17PM] ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge [2024-11-08 02:28AM] Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates [Nov-07-24 07:20PM] ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA) [2024-11-08 06:37AM] Q3 2024 ADMA Biologics Inc Earnings Call [2024-11-08 12:19PM]
08-08-2024	AH		ADMA	ADMA Biologics Inc	2,750	0.13	0.08	-0.02	ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M [8/8/2024 4:37 PM]	15.96	3.78 (30.97%)	14.99	2.80 (22.97%)	3.06 - 16.64	11,958,290	3,520,000	235,289
ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M [8/8/2024 4:37 PM] ADMA stock rallies 21% on raised guidance, earnings beat [8/8/2024 6:20 PM]
09-05-2024	AH		ADMA	ADMA Biologics Inc	1,580	0.08	0.05	-0.03	ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M [5/9/2024 4:23 PM]	8.82	1.89 (27.34%)	8.22	1.29 (18.61%)	3.06 - 9.02	10,952,779	2,260,000	240,527
ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M [5/9/2024 4:23 PM] ADMA Biologics hits 52-week high on Q1 beat, guidance raise [5/10/2024 3:31 PM]
28-02-2024	AH		ADMA	ADMA Biologics	1,189	0.04	0.02	0.00	ADMA Biologics GAAP EPS of -$0.08 misses by $0.11, revenue of $73.9M beats by $0.93M [2/28/2024 4:10 PM]	5.36	-0.02 (-0.46%)	5.31	-0.07 (-1.30%)	2.94 - 5.72	5,087,435	2,110,000	14,858
ADMA Biologics GAAP EPS of -$0.08 misses by $0.11, revenue of $73.9M beats by $0.93M [2/28/2024 4:10 PM] ADMA Biologics' CFO to step down [2/28/2024 4:16 PM]
08-11-2023	AH		ADMA	ADMA Biologics Inc	816.41	0.01	-0.01	-0.08	ADMA Biologics GAAP EPS of $0.01, revenue of $67.3M beats by $5.17M [11/8/2023 4:11 PM]	3.84	0.22 (6.08%)	3.99	0.37 (10.22%)	2.47 - 4.65	6,847,000	2,110,000	37,974
ADMA Biologics GAAP EPS of $0.01, revenue of $67.3M beats by $5.17M [11/8/2023 4:11 PM]
09-08-2023	AH		ADMA	ADMA Biologics Inc	920.21	-0.02	-0.02	-0.07	ADMA Biologics GAAP EPS of -$0.03 in-line, revenue of $60.13M beats by $4.63M [8/9/2023 4:20 PM]	4.29	0.23 (5.54%)	4.18	0.12 (2.96%)	1.99 - 4.64	9,828,844	1,640,000	3,582
ADMA Biologics GAAP EPS of -$0.03 in-line, revenue of $60.13M beats by $4.63M [8/9/2023 4:20 PM]
10-05-2023	AH	4:05 PM ET (May 10)	ADMA	ADMA Biologics Inc	777.87	-0.03	-0.05	-0.10	ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M [5/10/2023 4:11 PM]	3.96	0.40 (11.06%)	3.90	0.33 (9.24%)	1.43 - 4.03	8,197,139	1,890,000	69,415
ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M [5/10/2023 4:11 PM]
23-03-2023	AH	4:05 PM ET (Mar 23)	ADMA	ADMA Biologics Inc	775.37	-0.06	-0.06	-0.09	ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M [3/23/2023 4:06 PM]	3.29	0.18 (5.63%)	3.33	0.22 (7.07%)	1.43 - 3.98	3,276,373	3,360,000	48,695
ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M [3/23/2023 4:06 PM] ADMA Biologics expects first-time positive EBITDA by second half of year [3/23/2023 5:33 PM]
09-11-2022	AH	4:05 PM ET (Nov 9)	ADMA	ADMA Biologics Inc	496.78	-0.08	-0.08	-0.13	ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M [11/9/2022 4:17 PM]	3.14	0.67 (27.13%)	2.74	0.27 (10.93%)	1.17 - 3.19	14,402,406	2,100,000	26,062
ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M [11/9/2022 4:17 PM] ADMA Biologics hits 52-week high after strong Q3 beat [11/10/2022 3:45 PM] ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update [Nov-09-22 04:05PM] Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-22 05:35PM]
10-08-2022	AH	4:05 PM ET (Aug 10)	ADMA	ADMA Biologics Inc	426.08	-0.07	-0.09	-0.15	ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M [8/10/2022 4:10 PM]	2.22	0.10 (4.72%)	2.15	0.03 (1.42%)	1.01 - 2.48	6,248,891	1,600,000	19,110
ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M [8/10/2022 4:10 PM] Adma stock rises 10% after Q2 revenue nearly doubles, net loss narrows [8/11/2022 12:02 PM] ADMA Biologics, Inc. (NASDAQ:ADMA) insiders placed bullish bets worth US$580k in the last 12 months [Aug-10-22 07:16AM] ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update [Aug-10-22 04:05PM] Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates [Aug-10-22 05:25PM]
11-05-2022	AH	4:05 PM ET (May 11)	ADMA	ADMA Biologics Inc	301.98	-0.10	-0.08	-0.16	ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M [5/11/2022 4:10 PM]	1.68	0.25 (17.48%)	1.41	-0.02 (-1.40%)	1.01 - 2.15	3,668,542	3,440,000	13,183
ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M [5/11/2022 4:10 PM] ADMA Biologics up 4% after increasing 2022 revenue guidance [5/11/2022 5:03 PM] What Kind Of Shareholders Own ADMA Biologics, Inc. (NASDAQ:ADMA)? [May-10-22 06:30AM] ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update [May-11-22 04:05PM] Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates [May-11-22 05:45PM]
24-03-2022	AH	4:00 PM ET (Mar 24)	ADMA	ADMA Biologics Inc	313.30	-0.09	-0.10	-0.20	ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M [3/24/2022 4:19 PM]	1.62	0.12 (8.33%)	1.52	0.02 (1.33%)	1.01 - 2.63	5,288,862	2,019,253	280,408
ADMA Biologics gets FDA approval to extend shelf life of Asceniv, Bivigam [3/25/2022 7:28 AM] ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management [Mar-24-22 04:05PM] Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates [Mar-24-22 05:35PM] ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV & BIVIGAM® from 24 to 36 Months [Mar-25-22 07:00AM]
10-11-2021	AH	4:05 PM ET (Nov 10)	ADMA	ADMA Biologics Inc	266.31	-0.13	-0.15	-0.19	ADMA Biologics EPS beats by $0.01, beats on revenue [11/10/2021 4:10 PM]	1.58	0.18 (12.86%)	1.50	0.10 (7.14%)	1.01 - 3.11	11,638,631	2,190,000	1,005,438
ADMA Biologics EPS beats by $0.01, beats on revenue [11/10/2021 4:10 PM] ADMA Biologics raised to Strong Buy at Raymond James citing financial momentum [11/11/2021 1:02 PM] ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments [Nov-10-21 04:01PM] Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 05:35PM] ADMA Biologics Inc (ADMA) Q3 2021 Earnings Call Transcript [Nov-10-21 09:00PM] ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double [Nov-11-21 07:49AM]
11-08-2021	AH	4:05 PM ET (Aug 11)	ADMA	ADMA Biologics Inc	202.54	-0.15	-0.15	-0.23	ADMA Biologics EPS beats by $0.01, beats on revenue [8/11/2021 4:18 PM]	1.50	-0.03 (-1.96%)	1.59	0.06 (3.92%)	1.38 - 3.71	1,324,835	770,000	45,474
ADMA Biologics EPS beats by $0.01, beats on revenue [8/11/2021 4:18 PM] ADMA Biologics shares rise on Q2 earnings beat [8/11/2021 4:33 PM] ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics Persona Technology for NexSys Plasma Collection System [Aug-10-21 04:30PM] ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments [Aug-11-21 04:05PM] Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates [Aug-11-21 06:55PM] ADMA Biologics Inc (ADMA) Q2 2021 Earnings Call Transcript [Aug-12-21 12:00PM]
12-05-2021	AH	4:05 PM ET (May 12)	ADMA	ADMA Biologics Inc	214.10	-0.16	-0.17	-0.26	ADMA Biologics EPS beats by $0.01, beats on revenue [5/12/2021 4:07 PM]	1.62	-0.05 (-2.99%)	1.71	0.04 (2.40%)	1.45 - 4.20	3,787,179	5,530,000	24,756
ADMA Biologics EPS beats by $0.01, beats on revenue [5/12/2021 4:07 PM] ADMA Biologics shares rise on Q1 earnings beat [5/12/2021 4:31 PM] ADMA Biologics, Inc. to Host Earnings Call [May-12-21 02:30PM] ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments [May-12-21 04:05PM] ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript [May-12-21 09:00PM]
25-03-2021	AH	4:05 PM ET (Mar 25)	ADMA	ADMA Biologics Inc	196.66	-0.20	-0.17	-0.18	ADMA Biologics EPS misses by $0.02, beats on revenue [3/25/2021 4:08 PM]	1.80	-0.25 (-12.20%)	1.95	-0.10 (-4.88%)	1.73 - 4.20	5,703,861	2,950,000	91,132
ADMA Biologics EPS misses by $0.02, beats on revenue [3/25/2021 4:09 PM] ADMA Biologics EPS misses by $0.02, beats on revenue [3/25/2021 4:08 PM] ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-25-21 04:05PM] Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates [Mar-25-21 05:35PM] ADMA Biologics Inc (ADMA) Q4 2020 Earnings Call Transcript [Mar-25-21 07:30PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	ADMA	ADMA Biologics Inc	179.61	-0.19	-0.20	-0.19	ADMA Biologics EPS beats by $0.01, beats on revenue [11/5/2020 4:37 PM]	1.90	-0.20 (-9.72%)	2.06	-0.05 (-2.37%)	1.45 - 5.23	5,997,754	1,690,095	208,604

06-05-2020	AH		ADMA	ADMA Biologics Inc	271.12	-0.26	-0.13	-0.31		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0